Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

Clinical trial NCT06435351 · RECRUITING

Trial details

NCT number: NCT06435351
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Cancer Triple Negative Breast Cancer

Start date: 2024-06-12
Primary completion: 2029-05-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.